జర్నల్ ఆఫ్ డెర్మటైటిస్

నైరూప్య

Developmental Treatment Progress for Atopic Dermatitis

Zhou Paul

Atopic Dermatitis (AD) is a chronic skin illness caused by complicated interactions between skin barrier abnormalities and a deregulated immune system, which is characterized by the activation of diverse T cell subsets at various phases of the disease. Until recently, the majority of patients were treated with moisturizers, topical steroids and topical calcineurin inhibitors, with systemic immunosuppressant are being recommended in seriously sick patients. New treatment techniques have been conceived and developed in recent years to target the many phases in the chain of molecular processes that rise to the AD phenotype. The focus of this short communication will be on current advancements in the treatment of Alzheimer's disease.